Nathalie E Chalhoub, Scott E Wenderfer, Deborah M Levy, Kelly Rouster-Stevens, Amita Aggarwal, Sonia I Savani, Natasha M Ruth, Thaschawee Arkachaisri, Tingting Qiu, Angela Merritt, Karen Onel, Beatrice Goilav, Raju P Khubchandani, Jianghong Deng, Adriana R Fonseca, Stacy P Ardoin, Coziana Ciurtin, Ozgur Kasapcopur, Marija Jelusic, Adam M Huber, Seza Ozen, Marisa S Klein-Gitelman, Simone Appenzeller, André Cavalcanti, Lampros Fotis, Sern Chin Lim, Rodrigo M Silva, Julia Ramírez- Miramontes, Natalie L Rosenwasser, Claudia Saad-Magalhaes, Dieneke Schonenberg-Meinema, Christiaan Scott, Clovis A Silva, Sandra Enciso, Maria T Terreri, Alfonso-Ragnar Torres-Jimenez, Maria Trachana, Sulaiman M Al-Mayouf, Prasad Devarajan, Bin Huang, Hermine I Brunner
OBJECTIVE: To develop a standardized steroid dosing regimen (SSR) for physicians treating childhood-onset systemic lupus erythematosus (SLE) complicated by lupus nephritis (LN), using consensus formation methodology. METHODS: Parameters influencing corticosteroid (CS) dosing were identified (step 1). Data from children with proliferative LN were used to generate patient profiles (step 2). Physicians rated changes in renal and extrarenal childhood-onset SLE activity between 2 consecutive visits and proposed CS dosing (step 3)...
February 2022: Arthritis & Rheumatology